Solventum Corporation (SOLV)
(Delayed Data from NYSE)
$61.56 USD
-0.88 (-1.41%)
Updated May 16, 2024 04:00 PM ET
After-Market: $61.53 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Income Statements
Fiscal Year end for Solventum Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | NA | NA | NA | NA | NA |
Income After Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | NA | NA | NA |
Diluted Net EPS (GAAP) | -99,999.00 | -99,999.00 | NA | NA | NA |
Fiscal Year end for Solventum Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 2,016.00 | NA | NA | NA | NA |
Cost Of Goods | 844.00 | NA | NA | NA | NA |
Gross Profit | 1,172.00 | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 791.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 381.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | -13.00 | NA | NA | NA | NA |
Interest Expense | 39.00 | NA | NA | NA | NA |
Pretax Income | 329.00 | NA | NA | NA | NA |
Income Taxes | 92.00 | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | 237.00 | NA | NA | NA | NA |
Extras & Discontinued Operations | 0.00 | NA | NA | NA | NA |
Net Income (GAAP) | 237.00 | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 172.70 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 2.08 | -99,999.00 | NA | NA | NA |
Diluted Net EPS (GAAP) | 1.37 | -99,999.00 | NA | NA | NA |